876
Views
4
CrossRef citations to date
0
Altmetric
Research Papers

Infectivity-associated PrPSc and disease duration-associated PrPSc of mouse BSE prions

, , , &
Pages 394-403 | Received 10 Aug 2015, Accepted 17 Oct 2015, Published online: 21 Dec 2015

REFERENCES

  • Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363-83; PMID:9811807; http://dx.doi.org/10.1073/pnas.95.23.13363.
  • Safar JG, Kellings K, Serban A, Groth D, Cleaver JE, Prusiner SB, Riesner D. Search for a prion-specific nucleic acid. J Virol 2005; 79:10796-806; PMID:16051871; http://dx.doi.org/10.1128/JVI.79.16.10796-10806.2005.
  • Bolton DC, McKinley MP, Prusiner SB. Identification of a protein that purifies with the scrapie prion. Science 1982; 218:1309-11; PMID:6815801; http://dx.doi.org/10.1126/science.6815801.
  • Meyer RK, McKinley MP, Bowman KA, Braunfeld MB, Barry RA, Prusiner SB. Separation and properties of cellular and scrapie prion proteins. Proc Natl Acad Sci U S A 1986; 83:2310-4; PMID:3085093; http://dx.doi.org/10.1073/pnas.83.8.2310.
  • Pan KM, Baldwin M, Nguyen J, Gasset M, Serban A, Groth D, Mehlhorn I, Huang Z, Fletterick RJ, Cohen FE, et al. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A 1993; 90:10962-6; PMID:7902575; http://dx.doi.org/10.1073/pnas.90.23.10962.
  • Beekes M, Baldauf E, Diringer H. Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. J Gen Virol 1996; 77 ( Pt 8):1925-34; PMID:8760444; http://dx.doi.org/10.1099/0022-1317-77-8-1925.
  • Jendroska K, Heinzel FP, Torchia M, Stowring L, Kretzschmar HA, Kon A, Stern A, Prusiner SB, DeArmond SJ. Proteinase-resistant prion protein accumulation in Syrian hamster brain correlates with regional pathology and scrapie infectivity. Neurology 1991; 41:1482-90; PMID:1679911; http://dx.doi.org/10.1212/WNL.41.9.1482.
  • Bolton DC, Rudelli RD, Currie JR, Bendheim PE. Copurification of Sp33-37 and scrapie agent from hamster brain prior to detectable histopathology and clinical disease. J Gen Virol 1991; 72 ( Pt 12):2905-13; PMID:1684986; http://dx.doi.org/10.1099/0022-1317-72-12-2905.
  • Barron RM, Campbell SL, King D, Bellon A, Chapman KE, Williamson RA, Manson JC. High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 2007; 282:35878-86; PMID:17923484; http://dx.doi.org/10.1074/jbc.M704329200.
  • Lasmezas CI, Deslys JP, Robain O, Jaegly A, Beringue V, Peyrin JM, Fournier JG, Hauw JJ, Rossier J, Dormont D. Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 1997; 275:402-5; PMID:8994041; http://dx.doi.org/10.1126/science.275.5298.402.
  • Miyazawa K, Emmerling K, Manuelidis L. High CJD infectivity remains after prion protein is destroyed. J Cell Biochem 2011; 112:3630-7; PMID:21793041; http://dx.doi.org/10.1002/jcb.23286.
  • D'Castro L, Wenborn A, Gros N, Joiner S, Cronier S, Collinge J, Wadsworth JD. Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid. PloS One 2010; 5:e15679; PMID:21187933; http://dx.doi.org/10.1371/journal.pone.0015679.
  • Sajnani G, Silva CJ, Ramos A, Pastrana MA, Onisko BC, Erickson ML, Antaki EM, Dynin I, Vázquez-Fernández E, Sigurdson CJ, et al. PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP. PLoS Pathog 2012; 8:e1002547; PMID:22396643; http://dx.doi.org/10.1371/journal.ppat.1002547.
  • Owen JP, Rees HC, Maddison BC, Terry LA, Thorne L, Jackman R, Whitelam GC, Gough KC. Molecular profiling of ovine prion diseases by using thermolysin-resistant PrPSc and endogenous C2 PrP fragments. J Virol 2007; 81:10532-9; PMID:17652380; http://dx.doi.org/10.1128/JVI.00640-07.
  • Tremblay P, Ball HL, Kaneko K, Groth D, Hegde RS, Cohen FE, DeArmond SJ, Prusiner SB, Safar JG. Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol 2004; 78:2088-99; PMID:14747574; http://dx.doi.org/10.1128/JVI.78.4.2088-2099.2004.
  • Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G, Gabizon R, Taraboulos A. Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 2002; 41:12868-75; PMID:12379130; http://dx.doi.org/10.1021/bi025958g.
  • Krasemann S, Neumann M, Szalay B, Stocking C, Glatzel M. Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity. J Gen Virol 2013; 94:453-63; PMID:23136363; http://dx.doi.org/10.1099/vir.0.045922-0.
  • Kasai K, Iwamaru Y, Masujin K, Imamura M, Mohri S, Yokoyama T. Heterogeneity of the Abnormal Prion Protein (PrPSc) of the Chandler Scrapie Strain. Pathogens 2013; 2:92- 104; PMID:25436883; http://dx.doi.org/10.3390/pathogens2010092.
  • Tixador P, Herzog L, Reine F, Jaumain E, Chapuis J, Le Dur A, Laude H, Béringue V. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog 2010; 6:e1000859; PMID:20419156; http://dx.doi.org/10.1371/journal.ppat.1000859.
  • Silveira JR, Raymond GJ, Hughson AG, Race RE, Sim VL, Hayes SF, Caughey B. The most infectious prion protein particles. Nature 2005; 437:257-61; PMID:16148934; http://dx.doi.org/10.1038/nature03989.
  • Sandberg MK, Al-Doujaily H, Sharps B, Clarke AR, Collinge J. Prion propagation and toxicity in vivo occur in two distinct mechanistic phases. Nature 2011; 470:540-2; PMID:21350487; http://dx.doi.org/10.1038/nature09768.
  • Sajnani G, Requena JR. Prions, proteinase K and infectivity. Prion 2012; 6:430-2; PMID:23044510; http://dx.doi.org/10.4161/pri.22309.
  • Gavier-Widen D, Stack MJ, Baron T, Balachandran A, Simmons M. Diagnosis of transmissible spongiform encephalopathies in animals: a review. J Vet Diagn Invest 2005; 17:509-27; PMID:16475509; http://dx.doi.org/10.1177/104063870501700601.
  • Simoneau S, Rezaei H, Sales N, Kaiser-Schulz G, Lefebvre-Roque M, Vidal C, Fournier JG, Comte J, Wopfner F, Grosclaude J, et al. In vitro and in vivo neurotoxicity of prion protein oligomers. PLoS Pathog 2007; 3:e125; PMID:17784787; http://dx.doi.org/10.1371/journal.ppat.0030125.
  • Caughey B, Lansbury PT. Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 2003; 26:267-98; PMID:12704221; http://dx.doi.org/10.1146/annurev.neuro.26.010302.081142.
  • Czub M, Braig HR, Diringer H. Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally. J Gen Virol 1986; 67 ( Pt 9):2005-9; PMID:2875123; http://dx.doi.org/10.1099/0022-1317-67-9-2005.
  • Manuelidis L, Fritch W. Infectivity and host responses in Creutzfeldt-Jakob disease. Virology 1996; 216:46-59; PMID:8615006; http://dx.doi.org/10.1006/viro.1996.0033.
  • Sandberg MK, Al-Doujaily H, Sharps B, De Oliveira MW, Schmidt C, Richard-Londt A, Lyall S, Linehan JM, Brandner S, Wadsworth JD, et al. Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked. Nat Commun 2014; 5:4347; PMID:25005024; http://dx.doi.org/10.1038/ncomms5347.
  • Robinson MM, Cheevers WP, Burger D, Gorham JR. Organ-specific modification of the dose-response relationship of scrapie infectivity. J Infect Dis 1990; 161:783-6; PMID:2138656; http://dx.doi.org/10.1093/infdis/161.4.783.
  • Lax AJ, Millson GC, Manning EJ. Can scrapie titres be calculated accurately from incubation periods? J Gen Virol 1983; 64 (Pt 4):971-3; PMID:6403663; http://dx.doi.org/10.1099/0022-1317-64-4-971.
  • Somerville RA, Carp RI. Altered scrapie infectivity estimates by titration and incubation period in the presence of detergents. J Gen Virol 1983; 64 (Pt 9):2045-50; PMID:6411862; http://dx.doi.org/10.1099/0022-1317-64-9-2045.
  • Shikiya RA, Bartz JC. In vitro generation of high-titer prions. J Virol 2011; 85:13439-42; PMID:21957291; http://dx.doi.org/10.1128/JVI.06134-11.
  • Deleault NR, Lucassen RW, Supattapone S. RNA molecules stimulate prion protein conversion. Nature 2003; 425:717-20; PMID:14562104; http://dx.doi.org/10.1038/nature01979.
  • Deleault NR, Piro JR, Walsh DJ, Wang F, Ma J, Geoghegan JC, Supattapone S. Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids. Proc Natl Acad Sci U S A 2012; 109:8546-51; PMID:22586108; http://dx.doi.org/10.1073/pnas.1204498109.
  • Gilles HJ. [Calculation of the index of acute toxicity by the method of linear regression. Comparison with the method of "Karber and Behrens"]. Eur J Toxicol Environ Hyg 1974; 7:77-84; PMID:4408718.
  • Prusiner SB, Cochran SP, Downey DE, Groth DF. Determination of scrapie agent titer from incubation period measurements in hamsters. Adv Exp Med Biol 1981; 134:385-99; PMID:7194570; http://dx.doi.org/10.1007/978-1-4757-0495-2_35.
  • Lane AC, Stanley S, Dealler S, Wilson SM. Polymeric ligands with specificity for aggregated prion proteins. Clin Chem 2003; 49:1774-75; http://dx.doi.org/10.1373/49.10.1774.
  • Shimizu Y, Kaku-Ushiki Y, Iwamaru Y, Muramoto T, Kitamoto T, Yokoyama T, Mohri S, Tagawa Y. A novel anti-prion protein monoclonal antibody and its single-chain fragment variable derivative with ability to inhibit abnormal prion protein accumulation in cultured cells. Microbiol Immunol 2010; 54:112-21; PMID:20377745; http://dx.doi.org/10.1111/j.1348-0421.2009.00190.x.
  • Shinagawa M, Matsuda A, Sato G, Takeuchi M, Ichijo S, Ono T. Occurrence of ovine scrapie in Japan: clinical and histological findings in mice inoculated with brain homogenates of an affected sheep. Nihon Juigaku Zasshi 1984; 46:913-6; PMID:6441054; http://dx.doi.org/10.1292/jvms1939.46.913.